Former President Biden said the country is in the midst of “dark days” under President Trump. “Friends, I can’t sugar coat any of this. These are dark days,” Biden said in Boston on Sunday after ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding ...

The National Institute for Health and Care Excellence (NICE) has recommended darolutamide in combination with androgen ...

A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

Biden called the current political climate “dark days” but urged Americans to "keep the faith" and “get back up.” ...

Former President Joe Biden spoke publicly for the first time since completing a round of radiation therapy for an aggressive ...

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

Former President Joe Biden, in his first public address since finishing prostate cancer treatment, urged “optimism” in a time ...

Prostate cancer survivors Mark V. Williamson and Jim East will celebrate with other men who beat the disease, Nov. 16 at the ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.